Adaptive Biotechnologies Corp

Biotechnology

Based in WA

🤖

AI Overview

With $10K in lobbying spend across 3 quarterly filings, Adaptive Biotechnologies Corp is an active lobbying client. Their lobbying covers 3 issue areas.

$10K
Total Spend
1
Years Active
1
Firms Hired
1
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2022$10K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED, Medicare/Medicaid

  • H.R. 1428, The VALID Act NIH Appropriations
  • HR2471 Appropriations for NIH for T cell research in COVID19 and other disease areas; HR4128 and S2209 The VALID Act. Provisions related to first of a kind assays
  • 2023 appropriations requests for NIH for T cell research in COVID19 and other disease areas; HR4128 and S2209 The VALID Act. Provisions related to first of a kind assays

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.